Acute and Subchronic Effects of Nefazodone and Imipramine on Highway Driving, Cognitive Functions, and Daytime Sleepiness in Healthy Adult and Elderly Subjects
- 1 February 1995
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 15 (1) , 30-40
- https://doi.org/10.1097/00004714-199502000-00006
Abstract
The acute and subchronic effects of two dosages of a new serotonergic antidepressant, nefazodone, and those of the tricyclic imipramine were examined in a double-blind, crossover, placebo-controlled study. Twenty-four healthy subjects from two age groups (12 adults and 12 elderly from both sexes) received the four treatments (nefazodone, 100 and 200 mg twice daily; imipramine, 50 mg twice daily; and placebo) for 7 days with a 7-day washout period. Measurements were performed after the morning doses on day 1 and day 7. These included a standard over-the-road highway driving test, a psychomotor test battery, and sleep latency tests. Blood samples were taken on both days and analyzed to determine concentrations of parent drugs and their major metabolites. The main results showed that the reference drug, imipramine, had a detrimental effect after a single dose on lateral position control in the driving test, primarily in the adult group, that diminished after repeated dosing. Minor impairment on psychomotor test performance was found with both days. On the other hand, a single administration of both doses of nefazodone did not impair highway driving performance (even showed some improvement) and had no or only minor effects on psychomotor performance. After repeated dosing, nefazodone 200 mg twice daily (but not the 100-mg dose) produced slight impairment of lateral position control; dose-related impairment of cognitive and memory functions was found. The effects of nefazodone were generally in the same direction in both age groups. Significant correlations were found between steady-state concentrations of nefazodone in plasma (200-mg, twice-daily condition) as well as imipramine, and reaction time changes in a memory scanning task. Neither drug appeared to induce daytime sleepiness as measured by the sleep latency tests.Keywords
This publication has 26 references indexed in Scilit:
- The effects of nefazodone, imipramine and placebo, alone and combined with alcohol, in normal subjectsInternational Clinical Psychopharmacology, 1993
- A comparative study of on‐the‐road and simulated driving performance after nocturnal treatment with lormetazepam 1 mg and oxazepam 50 mgHuman Psychopharmacology: Clinical and Experimental, 1992
- Does cetirizine belong to the new generation of antihistamines? An investigation into its acute and subchronic effects on highway driving, psychometric test performance and daytime sleepinessHuman Psychopharmacology: Clinical and Experimental, 1992
- Adverse Effects of Antidepressants in the ElderlyDrugs & Aging, 1992
- Effects of Antidepressants on Human Performance: A ReviewJournal of Clinical Psychopharmacology, 1990
- 1-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brainBiological Psychiatry, 1989
- Guidelines for the Multiple Sleep Latency Test (MSLT): A Standard Measure of SleepinessSleep, 1986
- Critical flicker fusion (CFF) test for sedative effect of antidepressantsActa Psychiatrica Scandinavica, 1981
- Desipramine*and Imipramine**, alone and together with Alcohol in Relation to Driving SafetyPharmacopsychiatry, 1971
- Note on the construction of digram-balanced Latin squares.Psychological Bulletin, 1969